Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has severely impacted on public health, mainly on immunosuppressed patients, including solid organ transplant recipients. Vaccination represents a valuable tool for the prevention of severe SARS-CoV-2 infection, and the immuno...

Full description

Bibliographic Details
Main Authors: Irene Cassaniti, Marilena Gregorini, Federica Bergami, Francesca Arena, Josè Camilla Sammartino, Elena Percivalle, Ehsan Soleymaninejadian, Massimo Abelli, Elena Ticozzelli, Angela Nocco, Francesca Minero, Eleonora Francesca Pattonieri, Daniele Lilleri, Teresa Rampino, Fausto Baldanti
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
transplanted patients
SARS-CoV-2
BNT162b2 vaccine
third dose
kidney
DSA
Online Access:https://www.mdpi.com/2076-393X/10/6/921

Internet

https://www.mdpi.com/2076-393X/10/6/921

Similar Items